We are live on ! Find out more

1,621 hedge funds and large institutions have $126B invested in Merck in 2014 Q2 according to their latest regulatory filings, with 86 funds opening new positions, 615 increasing their positions, 679 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 59

14% more call options, than puts

Call options by funds: $852M | Put options by funds: $750M

1% more funds holding

Funds holding: 1,6031,621 (+18)

2% more capital invested

Capital invested by funds: $124B → $126B (+$2.04B)

0.27% more ownership

Funds ownership: 74.39%74.67% (+0.27%)

9% less repeat investments, than reductions

Existing positions increased: 615 | Existing positions reduced: 679

5% less funds holding in top 10

Funds holding in top 10: 147140 (-7)

Holders
1,621
Holders Change
+18
Holders Change %
+1.12%
% of All Funds
46.43%
Holding in Top 10
140
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-4.76%
% of All Funds
4.01%
New
86
Increased
615
Reduced
679
Closed
59
Calls
$852M
Puts
$750M
Net Calls
+$103M
Net Calls Change
-$175M

MRK Hedge Fund Activity: Q2 2014 in Review

1,621 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2014, worth a combined $126B — up 1.6% from $124B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new MRK positions and 59 closed out — a net gain of 27 holders — while 615 added to existing stakes and 679 trimmed.

The largest buyer was Norges Bank, adding an estimated $1.27B. The largest seller was Fidelity Investments, cutting an estimated $623M.

  • 1,621 institutional investors held Merck (MRK) as of Q2 2014, up from 1,603 in Q1 2014.
  • Funds reported $126B of Merck stock for Q2 2014, up 1.6% quarter-over-quarter.
  • 86 funds opened new Merck positions in Q2 2014 and 59 closed out, a net change of +27 holders.
  • The largest Merck buyer in Q2 2014 was Norges Bank, an estimated $1.27B added.
  • The largest Merck seller in Q2 2014 was Fidelity Investments, an estimated $623M sold.

Based on aggregated 13F filings for Q2 2014.